Merrill Lynch

Feb 20, 2015 at 11:17 | Source:
Shares of Aurobindo Pharma gained 3 percent intraday Friday as Bank of America Merrill Lynch (BoAML) reiterated its buy rating on the stock. The brokerage house sees 38 percent upside potential from current price level.
Feb 19, 2015 at 09:14 | Source: CNBC-TV18
Jyotivardhan Jaipuria, Bank of America Merrill Lynch says FIIs continued to invest in India with the December quarter witnessing FII flows of more than USD 2 billion. This was the 9th consecutive quarter of positive inflows from the FIIs, he adds.
Feb 17, 2015 at 15:27 | Source: PTI
According to global brokerage firms like, Bank of America Merrill Lynch, Barclays, Citigroup and HSBC, inflation is likely to stay "benign" through the year 2015.
Feb 10, 2015 at 12:17 | Source: Reuters
The offering comes just a week after Apple waded into the dollar market with a USD 6.5bn offering, its third in as many years to pay for share buybacks.
Feb 10, 2015 at 11:36 | Source:
Bank of America Merrill Lynch has a buy rating on the stock, suggesting to accumulate on dips. However, it expects L&T to register a 10 percent Y-o-Y decline in its Q4FY15 recurring PAT but says weak profits of Q4 will most likely be ignored by the street given potential of its robust guidance for FY16.
Feb 05, 2015 at 09:59 | Source:
Macquarie maintains an outperform rating on the stock with a target of Rs 425 per share as it feels the upcoming spectrum auctions will be key driver. It states, though spectrum auction will pinch the balance sheet in the near term, it should alleviate regulatory uncertainty in the long run.
Feb 04, 2015 at 11:09 | Source:
Goldman Sachs also retains buy rating with a potential upside of 11 percent but lowers target price to Rs 198 from Rs 228 earlier.
Feb 03, 2015 at 12:03 | Source: Reuters
HDFC Bank has said it does not have any immediate capital requirement, the share sale will help it build a buffer as credit growth picks up with an expected recovery in the economy.
Jan 28, 2015 at 08:58 | Source: CNBC-TV18
Jyotivardhan Jaipuria, Bank of America Merrill Lynch says India remains a consensus overweight but investors are not looking to trim their positions. Most investors are looking at dips to buy India.
Jan 21, 2015 at 11:01 | Source:
Bank of America Merrill Lynch maintains buy rating on the stock with a target of Rs 1600 per share as it expects merger with ING Vysya to be accretive for Kotak Mahindra in regard to valuations and positioning. BoA ML also thinks that the merger will provide upside to Kotak.
Messages on Merrill Lynch »


Platinum Member


Rain Commoditie  

.91%(21.75%). Fig in Brackets Represent Mar Qtr. The Block deals of Sale by Merril Lynch, "Purchased by ICICI Prudential" has Seen DII`s Increase Stake sharply in the Scrip. The Top 5 Institutional Shareholders are: Icici 9.41%: Reliance Capital 8.60% : CIR Intl 5.40% : Megahmala Entps 5.17% : Goldman Sachs 2

7.36 PM Jul 4th 2014


Platinum Member


Resurgere Mines  

1 Subhash Sharma 4093988 14.34 2 Merrill Lynch International 3000000 10.51 3 Runwell Mining Pvt Ltd 2017500 7.07 4 Neelam S Sharma 1843750 6.46 5 Eminent Mining Private Limited 1704450 5.97 6 Runwell Steel Private Limited 1500000 5.26 7 Neelam S Sharma 1475000 5.17 8 Victory Mining Private Limited

4.33 PM Jul 4th 2014

Web Messenger

Platinum Member


Gemini Comm  

Source:NDTV Profit - Mumbai: The Securities and Exchange Board of India (Sebi) on Monday settled charges of non-compliance of takeover norms against foreign institutional investor Merrill Lynch International after the company paid over Rs 40 lakh in settlement fees.

11.11 AM Jul 1st 2014


Platinum Member


Oswal ChemandFe  

and entertainment channels under the same brand, changed hands. While Merrill Lynch Capital Markets Espana sold its holding of over 51 lakh shares at Rs. 26.55 a share, Nomura Mauritius sold over 40 lakh shares each at Rs. 26.75, according to information made available to the Bombay Stock Exchange. The total deal

6.32 PM Jun 11th 2014

Market Statistician

Platinum Member


Sequent Scienti  

MERRILL LYNCH CAPITAL MARKETS ESPANA SA SV buys 400000 shares of Sequent Scienti at Rs 250.00 per share on BSE on June 03.

6.59 PM Jun 3rd 2014


Platinum Member



Brokerage house Bank of America Merrill Lynch has raised price target for SBI by 7 percent to Rs 3200, Citi has upped its target to Rs 3030 and Goldman Sachs to Rs 3200. CLSA has a target of Rs 3160 for the stock, and Axis Capital, Rs 3078. Macquarie belongs to camp which is still wary of SBI

11.37 AM May 26th 2014


Platinum Member


Monsanto India  

as a possible El Nino effect on the monsoon is likely to push up food prices and geopolitical uncertainties are likely to pump up global commodity rates. Echoing similar views, a Bank of AmericaMerrill Lynch (BofA-ML) report said an El Nino-induced drought poses a 50-75 basis points risk to India`s FY15

5.38 PM May 22nd 2014

Market Statistician

Platinum Member


MT Educare  

MERRILL LYNCH CAPITAL MARKETS ESPANA SA SV sells 408758 shares of MT Educare at Rs 95.05 per share on BSE on May 20.

9.29 PM May 20th 2014

Web Messenger

Platinum Member


Morgan Stanley  

Source:Economic Times - Shares of Dr. Reddy`s Laboratories Ltd slipped 2.3 per cent to 2,551 rupees, adding to their 4.1 per cent fall on Tuesday as the drugmaker continues to be hit by disappointment over its January-March earnings. Bank of America-Merrill Lynch downgraded the stock to

2.24 PM May 14th 2014


Gold Member


Rain Commoditie  

Rain should lie low and under 35 for a few months. Because ift it crosses Merrill Lynch sale price of Rs. 35, Merrill will be lynched by its investors. After Damodar and APM, my next identified under-priced scrip is Kalpena Industries. Buy for medium to long term under 51. Study for yourselves.

12.10 PM May 9th 2014

News across the web »
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.